Novartis Investigative Site

Midland Park, New Jersey 07432

0 studies enrolling now · 1 studies all time

What they study most

Ankylosing Spondylitis

Studies at this site

• Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis — Completed